Cargando…

Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma

BACKGROUND: No circulating markers are routinely used for renal cancer. The objective of this pilot study was to investigate whether conditioned media (CM) from renal cancer cell lines contains potential biomarkers that, when measured in clinical fluids, have diagnostic or prognostic utility. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasudev, N S, Sim, S, Cairns, D A, Ferguson, R E, Craven, R A, Stanley, A, Cartledge, J, Thompson, D, Selby, P J, Banks, R E
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768081/ https://www.ncbi.nlm.nih.gov/pubmed/19789534 http://dx.doi.org/10.1038/sj.bjc.6605250

Ejemplares similares

Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
por: Sim, S H, et al.
Publicado: (2012)

Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer
por: Wood, S L, et al.
Publicado: (2010)

Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein
por: Jagdev, S P K, et al.
Publicado: (2010)

miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis
por: McCormick, R I, et al.
Publicado: (2013)

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma
por: Konishi, H, et al.
Publicado: (2012)

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer
por: Miah, S, et al.
Publicado: (2012)

Changes in tumour vessel density upon treatment with anti-angiogenic agents: relationship with response and resistance to therapy
por: Vasudev, N S, et al.
Publicado: (2013)

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies
por: Roy, R, et al.
Publicado: (2014)

Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
por: Shimwell, N J, et al.
Publicado: (2013)

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014)

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer
por: Kelly, P, et al.
Publicado: (2012)

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
por: Bryan, R T, et al.
Publicado: (2015)

ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival
por: Brüning-Richardson, A, et al.
Publicado: (2011)

Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
por: Clark, S E, et al.
Publicado: (2011)

Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
por: Burcombe, R J, et al.
Publicado: (2005)

UV radiation promotes melanoma dissemination mediated by the sequential reaction axis of cathepsins–TGF-β1–FAP-α
por: Wäster, Petra, et al.
Publicado: (2017)

Fetal haemopoiesis marking low-grade urinary bladder cancer
por: Wolk, M, et al.
Publicado: (2012)

Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer
por: Torrisi, R, et al.
Publicado: (2007)

The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer
por: Gujam, F J A, et al.
Publicado: (2014)

Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer
por: Mohammed, Z M A, et al.
Publicado: (2012)

p53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumours with a higher risk of progression
por: Piaton, E, et al.
Publicado: (2005)

Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy
por: Dunn, J M, et al.
Publicado: (2010)

BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013)

Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins
por: Khadjavi, A, et al.
Publicado: (2015)

Prognostic value of microRNA expression in operable non-small cell lung cancer patients
por: Skrzypski, M, et al.
Publicado: (2014)

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer
por: Mohammed, Z M A, et al.
Publicado: (2013)

Testicular microlithiasis as a familial risk factor for testicular germ cell tumour
por: Coffey, J, et al.
Publicado: (2007)

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk
por: Katz, E, et al.
Publicado: (2010)

VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
por: Rennel, E S, et al.
Publicado: (2009)

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
por: Elsheikh, S E, et al.
Publicado: (2008)

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach
por: Hubers, A J, et al.
Publicado: (2015)

mRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma
por: Baren, J P, et al.
Publicado: (2012)

UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer
por: Unoki, M, et al.
Publicado: (2009)

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance
por: Sapre, Nikhil, et al.
Publicado: (2016)

Multiparameter DNA content analysis identifies distinct groups in primary breast cancer
por: Dayal, J H S, et al.
Publicado: (2013)

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
por: Luttmer, Roosmarijn, et al.
Publicado: (2016)

Assessment of DNA methylation status in early stages of breast cancer development
por: van Hoesel, A Q, et al.
Publicado: (2013)

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy
por: Bellone, S, et al.
Publicado: (2013)

The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy
por: Payne, R E, et al.
Publicado: (2012)

Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers
por: Green, A R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ir3kricibde0sa2klamshosnfa